Published in Eur J Immunol on June 01, 1999
NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J Exp Med (2007) 1.57
Candida albicans is phagocytosed, killed, and processed for antigen presentation by human dendritic cells. Infect Immun (2001) 1.34
Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor II for presentation to T lymphocytes. Infect Immun (2002) 1.31
Down-regulation of dendritic cell signaling pathways by Leishmania amazonensis amastigotes. Mol Immunol (2008) 1.20
CCR2 plays a critical role in dendritic cell maturation: possible role of CCL2 and NF-kappa B. J Immunol (2010) 1.20
Role of interleukin-1beta in activating the CD11c(high) CD45RB- dendritic cell subset and priming Leishmania amazonensis-specific CD4+ T cells in vitro and in vivo. Infect Immun (2007) 1.13
Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependent. Infect Immun (2002) 1.08
Cytokines and the inception of CD8 T cell responses. Trends Immunol (2011) 1.07
Modulation of dendritic cell responses by parasites: a common strategy to survive. J Biomed Biotechnol (2010) 1.02
The regulation of Th1 responses by the p38 MAPK. J Immunol (2010) 0.91
Interleukin-4 can induce interleukin-4 production in dendritic cells. Immunology (2006) 0.91
Activation of phosphatidylinositol 3-kinase/Akt and impairment of nuclear factor-kappaB: molecular mechanisms behind the arrested maturation/activation state of Leishmania infantum-infected dendritic cells. Am J Pathol (2010) 0.90
Leishmania major phosphoglycans influence the host early immune response by modulating dendritic cell functions. Infect Immun (2009) 0.89
The fraction 1 and V protein antigens of Yersinia pestis activate dendritic cells to induce primary T cell responses. Clin Exp Immunol (2007) 0.87
Leishmania major promastigotes inhibit dendritic cell motility in vitro. Infect Immun (2002) 0.87
Autoantigen-pulsed dendritic cells induce tolerance to experimental allergic encephalomyelitis (EAE) in Lewis rats. Clin Exp Immunol (2000) 0.85
Complement receptor 3 deficiency influences lesion progression during Leishmania major infection in BALB/c mice. Infect Immun (2009) 0.85
Pretreatment with recombinant Flt3 ligand partially protects against progressive cutaneous leishmaniasis in susceptible BALB/c mice. Infect Immun (2001) 0.84
Biogenesis of Leishmania major-harboring vacuoles in murine dendritic cells. Infect Immun (2006) 0.83
CD40 and the immune response to parasitic infections. Semin Immunol (2009) 0.81
Increased interleukin 4 (IL-4) receptor expression and IL-4-induced decrease in IL-12 production by Langerhans cells infected with Leishmania major. Infect Immun (2002) 0.80
Immunostimulatory properties of dendritic cells after Leishmania donovani infection using an in vitro model of liver microenvironment. PLoS Negl Trop Dis (2010) 0.78
Differential Impact of LPG-and PG-Deficient Leishmania major Mutants on the Immune Response of Human Dendritic Cells. PLoS Negl Trop Dis (2015) 0.75
Phagocytosis of bacille Calmette-Guérin-infected necrotic macrophages induces a maturation phenotype and evokes antigen-presentation functions in dendritic cells. Immunology (2002) 0.75
Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol (2001) 7.43
Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet (2000) 7.25
Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J Exp Med (1987) 5.14
Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol (2001) 3.79
Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate. Immunology (1986) 3.25
Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J Exp Med (1989) 3.16
Non-adherent, low-density cells from human peripheral blood contain dendritic cells and monocytes, both with veiled morphology. Immunology (1986) 2.72
Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood. Blood (1990) 2.68
Induction of immune responses in vivo with small numbers of veiled (dendritic) cells. Proc Natl Acad Sci U S A (1983) 2.68
Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology (1990) 2.58
Role of veiled cells in lymphocyte activation. Eur J Immunol (1982) 2.50
The role of dendritic cells in the initiation of immune responses to contact sensitizers. I. In vivo exposure to antigen. Cell Immunol (1985) 2.43
Susceptibility of human peripheral blood dendritic cells to infection by human immunodeficiency virus. J Gen Virol (1987) 2.38
Severity of imported falciparum malaria: effect of taking antimalarial prophylaxis. BMJ (1992) 2.36
Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut (2004) 2.29
A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine (1995) 2.03
Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol (1999) 2.01
Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J Immunol (1993) 2.00
Adverse reactions in expatriates treated with ivermectin. Lancet (1990) 1.98
Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J Exp Med (1999) 1.97
Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. J Infect (2005) 1.87
Veiled cells--"dendritic cells" of the peripheral lymph. Immunobiology (1984) 1.86
Pulmonary tuberculosis among political asylum seekers screened at Heathrow Airport, London, 1995-9. Thorax (2002) 1.84
The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut (2003) 1.84
Relapse of visceral leishmaniasis in patients who were coinfected with human immunodeficiency virus and who received treatment with liposomal amphotericin B. Clin Infect Dis (1994) 1.79
Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis (2009) 1.75
A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. Vaccine (1997) 1.70
Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome. Trans R Soc Trop Med Hyg (2002) 1.69
Conditions for measuring DNA synthesis in PHA stimulated human lymphocytes in 20 microliters hanging drops with various cell concentrations and periods of culture. J Immunol Methods (1980) 1.66
Severe falciparum malaria: predicting the effect of exchange transfusion. QJM (1994) 1.65
Migration and maturation of human colonic dendritic cells. J Immunol (2001) 1.64
The role of dendritic cells in the initiation of immune responses to contact sensitizers. II. Studies in nude mice. Cell Immunol (1985) 1.62
Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol (1994) 1.61
Suppression of immune responses by dendritic cells infected with HIV. Immunology (1989) 1.61
Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection. J Antimicrob Chemother (1998) 1.60
Exceptional lymphocyte stimulating capacity of cells from lymphoid cell lines. Nature (1969) 1.60
Immunologic reactivity in rheumatoid arthritis. Response to mitogens. Arthritis Rheum (1974) 1.52
Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation. AIDS Res Hum Retroviruses (1992) 1.45
Mineralocorticoid deficiency in HIV infection. BMJ (1989) 1.43
Defective low-density cells of dendritic morphology from the blood of patients with common variable hypogammaglobulinaemia: low immunoglobulin production on stimulation of normal B cells. Clin Exp Immunol (1985) 1.42
Bacillus anthracis on Gruinard Island. Nature (1981) 1.41
Morphology and phenotype of dendritic cells from peripheral blood and their productive and non-productive infection with human immunodeficiency virus type 1. Immunology (1991) 1.36
A single dose sub-unit vaccine protects against pneumonic plague. Vaccine (2000) 1.35
Group G streptococcal endocarditis: two case reports, a review of the literature and recommendations for treatment. J Infect (1988) 1.35
Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med (1995) 1.35
Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death. J Pediatr (1997) 1.32
Tuberculosis diagnosed during pregnancy: a prospective study from London. Thorax (2000) 1.32
The SCID/Beige mouse as a model to investigate protection against Yersinia pestis. FEMS Immunol Med Microbiol (1999) 1.31
Antigen-presenting cell types. Curr Opin Immunol (1993) 1.31
Veiled (dendritic) cells in synovial fluid. Lancet (1983) 1.30
Antigen-presentation by macrophages but not by dendritic cells in human immunodeficiency virus (HIV) infection. Immunology (1992) 1.30
Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. Eur Respir J (2009) 1.30
Under-reporting of malaria, a notifiable disease, in Britain. J Infect (1993) 1.29
Epidemic visceral leishmaniasis in Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone. J Infect Dis (1993) 1.29
Different roles for interleukin-4 during the course of Toxoplasma gondii infection. Infect Immun (1996) 1.29
Transmembrane domain of CD44 is required for its detergent insolubility in fibroblasts. J Cell Sci (1995) 1.27
Inflammatory disease in HLA-B27 transgenic rats. Immunol Rev (1999) 1.25
Rapid diagnosis of Falciparum malaria by using the ParaSight F test in travellers returning to the United Kingdom: prospective study. BMJ (2000) 1.25
Systemic migration of dendritic cells during contact sensitization. Immunology (1990) 1.24
Liposomal amphotericin B in the treatment of visceral leishmaniasis. J Antimicrob Chemother (1991) 1.24
Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells. Immunology (1991) 1.23
Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains. Vaccine (2000) 1.22
Ultrastructural appearance of freeze-substituted lymphocytes frozen by interrupting rapid cooling with a period at--26 degrees C. Cryobiology (1975) 1.21
Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome). J Infect (1996) 1.19
Emergence or re-emergence of visceral leishmaniasis in areas of Somalia, north-eastern Kenya, and south-eastern Ethiopia in 2000-01. Trans R Soc Trop Med Hyg (2004) 1.19
CD44 in inflammation and metastasis. Glycoconj J (1997) 1.16
Help and suppression by lymphoid cells as a function of cellular concentration. Proc Natl Acad Sci U S A (1979) 1.16
Suppression of collagen type II-induced arthritis by transfer of lymphoid cells from rats immunized with collagen. Clin Exp Immunol (1985) 1.15
Royal Society of Tropical Medicine and Hygiene joint meeting with Médecins Sans Frontières at Manson House, London, 20 March 2003: field research in humanitarian medical programmes. Médecins Sans Frontières interventions against kala-azar in the Sudan, 1989-2003. Trans R Soc Trop Med Hyg (2005) 1.14
Formaldehyde Solution Effectively Inactivates Spores of Bacillus anthracis on the Scottish Island of Gruinard. Appl Environ Microbiol (1994) 1.14
T cell responses to a mixture of Mycobacterium tuberculosis peptides with complementary HLA-DR binding profiles. Clin Exp Immunol (1996) 1.14
Activity of liposomal amphotericin B (AmBisome) against Leishmania infantum and tissue distribution in mice. J Drug Target (1993) 1.14
Primary human T-cell responses to the major outer membrane protein of Chlamydia trachomatis. Immunology (1993) 1.13
Production of interleukin (IL)-10 and IL-12 by murine colonic dendritic cells in response to microbial stimuli. Clin Exp Immunol (2005) 1.13
Role of CD44 cytoplasmic domain in hyaluronan binding. Eur J Immunol (1995) 1.11
The role of the gut flora in health and disease, and its modification as therapy. Aliment Pharmacol Ther (2002) 1.10
Optimal recovery of lymphocytes and tissue culture cells following rapid cooling. Nature (1974) 1.10
Separation of populations of human lymphocytes by freezing and thawing. Nat New Biol (1972) 1.10
Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease. Gut (2005) 1.09
Double-blind controlled trial of immunosuppression in the treatment of multiple sclerosis: final report. Lancet (1982) 1.09
Dendritic cells infected in vitro with human T cell leukaemia/lymphoma virus type-1 (HTLV-1); enhanced lymphocytic proliferation and tropical spastic paraparesis. Clin Exp Immunol (1993) 1.08
Protection against ascending infection of the genital tract by Chlamydia trachomatis is associated with recruitment of major histocompatibility complex class II antigen-presenting cells into uterine tissue. Infect Immun (1998) 1.07
Double-blind, controlled trial of immunosuppression in treatment of multiple sclerosis. Lancet (1980) 1.06
Retrovirally induced switch from production of IL-12 to IL-4 in dendritic cells. Eur J Immunol (1999) 1.05
Quantification and cytokine production of circulating lymphoid and myeloid cells in acute myelogenous leukaemia. Leukemia (2003) 1.04
Treatment of visceral leishmaniasis in children with liposomal amphotericin B. J Pediatr (1997) 1.04
Class II histocompatibility antigens on human dendritic cells. Immunology (1987) 1.03
HLA-B27 subtypes in the spondarthropathies. Clin Exp Immunol (1993) 1.03
Changes in the populations of lymphoid cells in human peripheral blood following physical exercise. Clin Exp Immunol (1984) 1.03
Efficacy of the latest fluoroquinolones against experimental Yersinia pestis. Int J Antimicrob Agents (2004) 1.03
Influence of a single oral dose of vitamin D(2) on serum 25-hydroxyvitamin D concentrations in tuberculosis patients. Int J Tuberc Lung Dis (2009) 1.03
Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom. Trans R Soc Trop Med Hyg (1993) 1.02
Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain. Microb Pathog (2004) 1.02